Peter S. Amenta, M.D., Ph.D.
Background
PETER S. AMENTA, M.D., Ph.D., most recently served as the President and CEO of the Harvard Medical School affiliate, Joslin Diabetes Center (2015–2019), the world-renowned institute centered on diabetes care and research. A former member of Joslin’s Board of Trustees, Dr. Amenta is also well-known clinician and scientist with significant administrative experience in medical education, academic health care management, and research development.
Dr. Amenta also served as Dean of UMDNJ-Robert Wood Johnson Medical School (RWJMS) 2006 – 2013, the founding dean of the new Rutgers-RWJMS in 2013; and concurrently the CEO of the RWJ Medical Faculty Practice. He was a faculty member/practitioner of Rutgers-RWJMS and RWJ University Hospital from 1989 to 2015.
During his 26-plus years at RWJMS and University Hospital, Dr. Amenta held a number of key administrative positions, including Chief of the Pathology Service and Senior Vice President of Medical Affairs and Chief of Staff at RWJUH, as well as Residency Program Director and Chair of the Department of Pathology and Laboratory Medicine at RWJMS. He was the founding Director of the Cancer Institute of New Jersey’s Immunohistochemistry Shared Resource, and a member of the Cancer Institute’s Scientific Council and Internal Advisory Board. He is a board certified anatomic and clinical pathologist. His research contributed to our understanding of novel connective tissue components during development and disease, as well as the pathogenesis of gastrointestinal diseases. He served on the Editorial Board of Human Pathology and as a reviewer for a number of other clinical and research journals. He has published more than 175 manuscripts, chapters and abstracts, including co-editing the textbook Histology-From Normal Microanatomy to Pathology.
Dr. Amenta holds a bachelor of science from Trinity College in Hartford, CT, and received his medical degree at Hahnemann University in Philadelphia, PA, where he also obtained his Ph.D. in anatomy.